Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/23/2000WO2000070061A2 Senescence-related promoters
11/23/2000WO2000070060A1 Production of complex carbohydrates
11/23/2000WO2000070059A2 Signal transduction genes and methods of use
11/23/2000WO2000070058A2 Plant cellulose synthase genes
11/23/2000WO2000070057A2 Mutant 1,3-propanediol dehydrogenase
11/23/2000WO2000070056A1 Chloramphenicol biosynthetic pathway and gene cluster characterization
11/23/2000WO2000070055A1 Rnp originating in paramyxovirus
11/23/2000WO2000070054A1 Pathogen-resistant grape plants
11/23/2000WO2000070053A1 Transgenic plants exhibiting an altered flowering time
11/23/2000WO2000070052A1 Gene isolated from ricinus communis encoding a new protein that interacts with the oleate 12-hydroxylase enzyme
11/23/2000WO2000070051A1 NEUROPROTECTIVE PROPERTIES OF GDF-15, A NOVEL MEMBER OF THE TGF-β SUPERFAMILY
11/23/2000WO2000070050A1 Compositions and methods for the treatment of immune related diseases
11/23/2000WO2000070049A2 Extracellular signaling molecules
11/23/2000WO2000070048A1 POLYNUCLEOTIDE AND POLYPEPTIDE SEQUENCES ENCODING MURINE ORGANIC ANION TRANSPORTER 6 (mOATP6) AND SCREENING METHODS THEREOF
11/23/2000WO2000070047A2 Full-length molecules expressed in human tissues
11/23/2000WO2000070046A2 Secreted polypeptides and corresponding polynucleotides
11/23/2000WO2000070045A1 Ox2 receptor homologs
11/23/2000WO2000070044A2 Human brain t calcium channel alpha-subunit splice variants
11/23/2000WO2000070043A1 Recombinant human mannan-binding lectin
11/23/2000WO2000070042A1 143 human secreted proteins
11/23/2000WO2000070041A1 Mixed-bed solid phase and its use in the isolation of nucleic acids
11/23/2000WO2000070040A1 Cell concentration and lysate clearance using paramagnetic particles
11/23/2000WO2000070039A1 METHOD FOR SUBTRACTING cDNAs BY SUPPRESSING THE SYNTHESIS OF SPECIFICALLY TARGETED mRNAs
11/23/2000WO2000070038A1 Plasmids and methods for construction of non-redundant, saturation, gene-disruption plant libraries
11/23/2000WO2000070037A2 Directed evolution of microorganisms
11/23/2000WO2000070036A2 Genes expressed in hippocampus
11/23/2000WO2000070032A1 Zace2: a human metalloenzyme
11/23/2000WO2000070028A1 Sphingosine kinase enzyme
11/23/2000WO2000070027A1 Materials and methods for enzymatic n-acetylation of arylalkylamines
11/23/2000WO2000070023A1 Novel fab fragment libraries and methods for their use
11/23/2000WO2000070021A2 Differentiated human embryoid cells and a method for producing them
11/23/2000WO2000070019A2 Process of rapid variety-independent plant transformation
11/23/2000WO2000070017A2 Methods using of fab i and compounds modulating fab i activity
11/23/2000WO2000070016A2 Genetically modified plants tolerant of stress conditions
11/23/2000WO2000069913A1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000069912A1 Gene encoding a sodium channel beta-3 subunit protein
11/23/2000WO2000069910A1 Chemokine-like factors having cell chemokinesis function and proliferation-stimulating activity
11/23/2000WO2000069907A1 Protein scaffold and its use to multimerise monomeric polypeptides
11/23/2000WO2000069905A1 LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069904A1 LAWSONIA DERIVED GENE AND RELATED FlgE POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069903A1 LAWSONIA DERIVED GENE AND RELATED SodC POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
11/23/2000WO2000069901A2 Proteins with insulin-like activity useful in the treatment of diabetes
11/23/2000WO2000069899A1 Compositions of solvents and high concentrations of nucleic acid analogs
11/23/2000WO2000069895A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069894A2 Novel indications of mannan-binding lectin (mbl) in the treatment of immunocompromised individuals
11/23/2000WO2000069891A2 Previns as specific inhibitors and therapeutic agents for botulinum toxin b and tetanus neurotoxins
11/23/2000WO2000069888A1 Self-assembling biomolecular structures
11/23/2000WO2000069885A2 Secreted proteins and uses thereof
11/23/2000WO2000069884A2 Compositions isolated from skin cells and methods for their use
11/23/2000WO2000069883A1 Methods for increasing plant cell proliferation by functionally inhibiting a plant cyclin inhibitor gene
11/23/2000WO2000069872A2 pH DEPENDENT ION EXCHANGE MATRIX AND METHOD OF USE IN THE ISOLATION OF NUCLEIC ACIDS
11/23/2000WO2000069462A1 Human monoclonal antibody
11/23/2000WO2000069455A2 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
11/23/2000WO2000069454A1 Suppression of endogenous igfbp-2 to inhibit cancer
11/23/2000WO2000069268A1 Production of human cells, tissues, and organs in animals
11/23/2000WO2000069257A2 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/23/2000WO2000050609B1 MAIZE ADENOSINE DEAMINASE cDNA AND USES THEREOF
11/23/2000WO2000046375A3 Methods for producing polypeptides in fungal cells
11/23/2000WO2000046245A3 Human antibiotic proteins
11/23/2000WO2000043410A3 Novel odorant receptors in drosophila
11/23/2000WO2000042560A3 Methods for making character strings, polynucleotides and polypeptides
11/23/2000WO2000041558A3 Interspecific nicotiana hybrids and their progeny
11/23/2000WO2000040759A3 Uses of flavivirus rna-dependent rna polymerases
11/23/2000WO2000040615A3 EXPRESSION AND EXPORT OF ANTI-OBESITY PROTEINS AS Fc FUSION PROTEINS
11/23/2000WO2000038706A3 Methods for treating cancer and for mediating chemotaxis of dendritic cells
11/23/2000WO2000037685A9 Method of identifying a psychotropic agent using differential gene expression
11/23/2000WO2000037608A3 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
11/23/2000WO2000037502A3 Vascular endothelial cell growth factor antagonists and uses thereof
11/23/2000WO2000036910A9 Msh5 ablated mice and uses therefor
11/23/2000WO2000036124A3 Plant cell cycle genes and uses thereof
11/23/2000WO2000036092A3 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION
11/23/2000WO2000034500A3 Methods for increasing the efficiency of gene transfer
11/23/2000WO2000032782A3 Plant transcription factors
11/23/2000WO2000032757A3 Plant vitamin e biosynthetic enzymes
11/23/2000WO2000032221A3 Promotion or inhibition of angiogenesis and cardiovascularization
11/23/2000WO2000031283A3 Regulatory sequences useful for gene expression in plant embryo tissue
11/23/2000WO2000031262A3 Human neurotensin subtype 2 receptor
11/23/2000WO2000031242A3 Engineered cytotoxic ribonuclease
11/23/2000WO2000029420A3 Methods of making modified nucleosides
11/23/2000WO2000028057A3 PLANT AMINOACYL-tRNA SYNTHETASES
11/23/2000WO2000028031A3 Mitogenic regulators
11/23/2000WO2000028020A3 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
11/23/2000WO2000028011A3 Fk506-based regulation of biological events
11/23/2000WO2000027994A3 Chlamydia pneumoniae genome sequence
11/23/2000WO2000027429A3 Vaccine against papillomatous digital dermatitis (pdd)
11/23/2000WO2000026357A3 Transgenic and cloned mammals
11/23/2000WO2000026348A3 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
11/23/2000WO2000023100A3 Genes and proteins predictive and therapeutic for renal disease and associated disorders
11/23/2000WO2000022144A3 Means and methods for modulating stomata characteristica in plants
11/23/2000WO2000020450A3 Calcium channel alpha-2/delta gene
11/23/2000WO2000018881A3 Intein mediated peptide ligation
11/23/2000WO2000017369A3 Alzheimer's disease secretase
11/23/2000WO2000016746A3 Immunogenic liposome compositions
11/23/2000WO2000015790A3 Leptin induced genes
11/23/2000WO2000015666A3 Compositions and methods for the treatment of tumors
11/23/2000WO2000012740A3 Adenoviruses deleted in the iva2, 100k and/or preterminal protein sequences
11/23/2000WO2000009666A3 Differentiation of non-insulin producing cells into insulin producing cells by glp-1 or exendin-4 and uses thereof
11/23/2000WO2000008157A3 Human anion transporter genes atnov
11/23/2000WO2000007545A3 Apoptosis proteins
11/23/2000WO1999057536A3 Cyclin activation kinase (cak) from human pathogens, and uses related thereto